News: Accounts

Neiman tapped as creative partner for portfolio of leading women's-health and personal-care brands

After a competitive review, Insight Pharmaceuticals has selected Neiman as creative partner for its portfolio of over-the-counter (OTC) women's health and personal care brands.

Insight Pharmaceuticals' brands include e.p.t.®, MONISTAT ®, Sucrets ® and Anacin ®, among others.

"Our business model is to add value to the consumer brands we acquire through smart, creative marketing," said Jennifer J. Moyer, Insight's Vice President of Marketing. "Marketing is not an ancillary operation for us - it's the heart of our business. And so we are very choosy about the agencies we partner with to add that value. Neiman's work - both historically, and throughout our rigorous competition - showed us they are the strategic business planners we value, the creative thinkers we cherish and the kind of people we like - people who work hard, take smart risks and try to have a little fun along the way."

"We're thrilled to add these national brands to our roster - but we're even more delighted to be working with the great people at Insight," said Neiman CEO Tim Reeves. "Insight CEO Gary Downing has built an amazing team - a national leader in their category, and an underappreciated gem in the Philadelphia business community. We fashion ourselves similarly. We're proud to be the newest member of Gary's team - and eager to help him and Jen take Insight to even greater heights."

"Insight wanted a creative partner who could help them to create purposeful conversations with each of their brands' consumers," said Neiman President Amy Muntz. "That's the kind of client and assignment that great agencies crave, and it's an honor to have won."

Neiman's RFP effort was led by Neiman Executive Creative Director Rich Wakefield and Client Services VP Mike Raetsch. Reeves and Muntz recruited Wakefield and Raetsch to the Neiman leadership team last year, along with the agency's newly promoted VP of Innovation, George Ward. Ward runs Neiman's R&D unit, Neiman Labs.

About Insight Pharmaceuticals:
Insight Pharmaceuticals is an innovative and fast-growing consumer products company that was founded in 1996 with the express mission of acquiring underperforming niche consumer OTC products. Insight Pharmaceuticals' strategy is to generate growth by acquiring brands with solid consumer equity that can be further developed through their merchandising and marketing expertise. The company strengthens its portfolio of brands by employing a variety of strategies, all with an in-depth understanding of the heritage of the brand and the needs of the consumer. Additional information about Insight Pharmaceuticals can be found at www.InsightPharma.com.

About Neiman
Neiman is a 32-year-old startup that is creating brand conversations for great business partners such as Dietz & Watson, Sunoco and Trex. Meanwhile, Neiman's R&D unit, Neiman Labs, is creating tomorrow's brand conversations. Two of the latest Labs innovations can be found at GoCrowdless.com and PhillySteakOut.com